We are open to cooperation with clinicians as well as scientists and investors focused on regenerative medicine. As part of the Institute’s activities, it is possible to treat both large and small animals in stationary patients using the therapeutic strategies we offer. What distinguishes us is the high therapeutic standards and the quality guarantee of the therapies developed by us. Regenerative therapies developed by MIMT are available to patients only on the recommendation of the treating physician.